ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 110 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,074,485 | -9.8% | 5,948,022 | +2.2% | 0.00% | – |
| Q2 2023 | $13,384,514 | -21.7% | 5,819,354 | +3.2% | 0.00% | – |
| Q1 2023 | $17,092,842 | +36.7% | 5,641,202 | +5.1% | 0.00% | – |
| Q4 2022 | $12,500,508 | +24.3% | 5,365,025 | +1.9% | 0.00% | – |
| Q3 2022 | $10,058,000 | -28.6% | 5,265,884 | +1.2% | 0.00% | – |
| Q2 2022 | $14,095,000 | -0.2% | 5,201,399 | +9.8% | 0.00% | – |
| Q1 2022 | $14,120,000 | -20.3% | 4,738,178 | +4.0% | 0.00% | – |
| Q4 2021 | $17,721,000 | +9.7% | 4,555,494 | +21.0% | 0.00% | – |
| Q3 2021 | $16,156,000 | +42.7% | 3,765,979 | +0.8% | 0.00% | – |
| Q2 2021 | $11,321,000 | +20.0% | 3,736,233 | +31.9% | 0.00% | – |
| Q1 2021 | $9,431,000 | -3.3% | 2,832,227 | +3.1% | 0.00% | – |
| Q4 2020 | $9,755,000 | +39.1% | 2,747,759 | +22.6% | 0.00% | – |
| Q3 2020 | $7,015,000 | +111.1% | 2,240,898 | +22.7% | 0.00% | – |
| Q2 2020 | $3,323,000 | +195.6% | 1,825,931 | +64.0% | 0.00% | – |
| Q1 2020 | $1,124,000 | -36.4% | 1,113,248 | +75.1% | 0.00% | – |
| Q4 2019 | $1,768,000 | +231.7% | 635,808 | +82.1% | 0.00% | – |
| Q3 2019 | $533,000 | +22.5% | 349,231 | +66.9% | 0.00% | – |
| Q2 2019 | $435,000 | -57.0% | 209,193 | -26.0% | 0.00% | – |
| Q1 2019 | $1,012,000 | -7.5% | 282,626 | -1.1% | 0.00% | – |
| Q4 2018 | $1,094,000 | -59.3% | 285,736 | +0.4% | 0.00% | – |
| Q3 2018 | $2,688,000 | +313.5% | 284,476 | +219.9% | 0.00% | – |
| Q2 2018 | $650,000 | +33.2% | 88,934 | +13.1% | 0.00% | – |
| Q3 2017 | $488,000 | +74.9% | 78,634 | +1.6% | 0.00% | – |
| Q2 2017 | $279,000 | +13.9% | 77,413 | +2.7% | 0.00% | – |
| Q1 2017 | $245,000 | +33.9% | 75,378 | +1.2% | 0.00% | – |
| Q4 2016 | $183,000 | -27.7% | 74,490 | +1.3% | 0.00% | – |
| Q3 2016 | $253,000 | +10.0% | 73,565 | +11.3% | 0.00% | – |
| Q2 2016 | $230,000 | -24.8% | 66,076 | -10.8% | 0.00% | – |
| Q1 2016 | $306,000 | -5.0% | 74,067 | +2.2% | 0.00% | – |
| Q4 2015 | $322,000 | – | 72,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |